La Vanguardia, La Razón, Correo Farmacéutico, Health Canal, among other national and international media, have published an article about the research led by Antonio Zorzano, from IRB Barcelona, and Fernando Albericio, from the University of Barcelona. This study reveals activators of mitochondrial protein Mitofusin 2 that may be valuable in the treatment of type 2 diabetes.
Link to La Vanguardia
Link to Correo Farmacéutico
Link to Health Canal
The Institute has signed a 5-year collaboration agreement to promote the exchange of faculty members and scientific collaboration with the Hokkaido University.
The newspaper El País has published an article on the pros and cons of intermittent fasting. The article refers to two kinds of fasting, namely the 5:2 fast, on which you can eat with no calorie restriction for five days and on the other two days no solids are allowed, and the 18:6 fast, which proposes that all the meals of the day are eaten within 6 hours, while the remaining 18 are devoted to fasting.
A project headed by Antonio Zorzano at IRB Barcelona has been awarded funding from the BBVA Foundation to explore a possible link between ageing and cancer.
Called MitoFuss, the project focuses on the mitochondrial protein Mitofusin 2.
